BlackRock Japan’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

BlackRock Japan’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,978	Closed	-$45K	–	1507
2016 Q2	$45K	Buy	+2,978	New	+$38.3K	﹤0.01%	1015
2015 Q3	–	Sell	-1,339	Closed	-$33K	–	1441
2015 Q2	$33K	Sell	1,339 -918	-41%	-$22K	﹤0.01%	1135
2015 Q1	$52K	Sell	2,257 -1,523	-40%	-$40.3K	﹤0.01%	1057
2014 Q4	$95K	Buy	+3,780	New	+$111K	﹤0.01%	979
2013 Q4	–	Sell	-6,175	Closed	-$126K	–	1485
2013 Q3	$126K	Buy	6,175 +1,514	+32%	+$33.7K	﹤0.01%	974
2013 Q2	$98K	Buy	+4,661	New	+$83.3K	﹤0.01%	984

BlackRock Japan's SGNT Position: Q3 2016 in Review

BlackRock Japan sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 2,978 shares — an estimated $45K sold.

BlackRock Japan first reported a position in SGNT in Q2 2013 and held it in 6 quarters. The position peaked at $126K in Q3 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

BlackRock Japan reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
BlackRock Japan sold 2,978 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $45K.
BlackRock Japan first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
BlackRock Japan's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $126K in Q3 2013.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.